Beyond this, the technological advances pioneered through model organism research, such as GFP, transgenic overexpression analyses, the Gal-4/UAS system, genetic screening, phenotype analysis, and drug screening have exponentially advanced our capacity to unravel mechanisms and define therapeutic targets for dystonia. Here, LGALS4 is linked to Dystonia.